Natroceutics Glutathione SOD Advanced Cellular Antioxidant Protection
Semaglutide GLP-1, a GLP-1 receptor agonist , mimics incretin hormones, enhancing insulin secretion, slowing gastric emptying, and reducing appetite, achieving up to 15% weight loss, with an average reduction of 12.4%
GLP-1 can stimulate insulin production in pancreatic beta-cells, suppress glucagon in pancreatic alpha-cells, reduce appetite signalling from the brain, and slow down gastric emptying in the stomach, all of which work in conjunction to decrease blood glucose levels ( Nauck 852)
The FDA has issued multiple 2024 and 2025 warning letters about counterfeit semaglutide and tirzepatide that contained either no active ingredient or completely different substances
Value of GLP-1 receptor agonists versus long-acting insulins for type 2 diabetes patients with and without established cardiovascular or chronic kidney diseases: A model-based cost-effectiveness analysis using real-world data
Ghosh, K